Amicus Therapeutics
Clinical trials sponsored by Amicus Therapeutics, explained in plain language.
Amicus Therapeutics
FOLD
NASDAQ
A biotech company developing treatments for rare diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.